IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Newron Pharmaceuticals SPA

CUSIP: T6916C102 | 1 institutional holders

Quarters

Q3 2020
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2020

Staley Capital Advisers Inc10,000
0.0% of portfolio›$21
StyleTurnoverLocationFiled
Staley Capital Advisers Inc
10,000$210.0%ValueLowPittsburgh, PA2020-11-13